Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic Approach to the Patients with Suspected Primary Immunodeficiency.
Tavakol M, Jamee M, Azizi G, Sadri H, Bagheri Y, Zaki-Dizaji M, Mahdavi FS, Jadidi-Niaragh F, Tajfirooz S, Kamali AN, Aghamahdi F, Noorian S, Kojidi HT, Mosavian M, Matani R, Dolatshahi E, Porrostami K, Elahimehr N, Fatemi-Abhari M, Sharifi L, Arjmand R, Haghi S, Zainaldain H, Yazdani R, Shaghaghi M, Abolhassani H, Aghamohammadi A. Tavakol M, et al. Among authors: shaghaghi m. Endocr Metab Immune Disord Drug Targets. 2020;20(2):157-171. doi: 10.2174/1871530319666190828125316. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31456526 Review.
Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (CVID).
Ganjalikhani-Hakemi M, Yazdani R, Esmaeili M, Abolhassani H, Rae W, Azizi G, Dizaji MZ, Shaghaghi M, Rezaei A, Abbasi-Rad F, Afshar-Qasemloo S, Mohammadi S, Rezaei N, Aghamohammadi A. Ganjalikhani-Hakemi M, et al. Among authors: shaghaghi m. Endocr Metab Immune Disord Drug Targets. 2017 Nov 16;17(4):332-340. doi: 10.2174/1871530317666170919120245. Endocr Metab Immune Disord Drug Targets. 2017. PMID: 28925897
Clinical, Immunological, and Genetic Features in 49 Patients With ZAP-70 Deficiency: A Systematic Review.
Sharifinejad N, Jamee M, Zaki-Dizaji M, Lo B, Shaghaghi M, Mohammadi H, Jadidi-Niaragh F, Shaghaghi S, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Sharifinejad N, et al. Among authors: shaghaghi m, shaghaghi s. Front Immunol. 2020 May 5;11:831. doi: 10.3389/fimmu.2020.00831. eCollection 2020. Front Immunol. 2020. PMID: 32431715 Free PMC article.
Epidemiology and pathophysiology of malignancy in common variable immunodeficiency?
Tak Manesh A, Azizi G, Heydari A, Kiaee F, Shaghaghi M, Hossein-Khannazer N, Yazdani R, Abolhassani H, Aghamohammadi A. Tak Manesh A, et al. Among authors: shaghaghi m. Allergol Immunopathol (Madr). 2017 Nov-Dec;45(6):602-615. doi: 10.1016/j.aller.2017.01.006. Epub 2017 Apr 12. Allergol Immunopathol (Madr). 2017. PMID: 28411962 Review.
Circulating Helper T-Cell Subsets and Regulatory T Cells in Patients With Common Variable Immunodeficiency Without Known Monogenic Disease.
Azizi G, Mirshafiey A, Abolhassani H, Yazdani R, Jafarnezhad-Ansariha F, Shaghaghi M, Mortazavi-Jahromi SS, Noorbakhsh F, Rezaei N, Aghamohammadi A. Azizi G, et al. Among authors: shaghaghi m. J Investig Allergol Clin Immunol. 2018;28(3):172-181. doi: 10.18176/jiaci.0231. Epub 2018 Jan 18. J Investig Allergol Clin Immunol. 2018. PMID: 29345621 Free article.
Polyautoimmunity in Patients with LPS-Responsive Beige-Like Anchor (LRBA) Deficiency.
Azizi G, Abolhassani H, Zaki-Dizaji M, Habibi S, Mohammadi H, Shaghaghi M, Yazdani R, Anaya JM, Rezaei N, Hammarström L, Aghamohammadi A. Azizi G, et al. Among authors: shaghaghi m. Immunol Invest. 2018 Jul;47(5):457-467. doi: 10.1080/08820139.2018.1446978. Epub 2018 Mar 12. Immunol Invest. 2018. PMID: 29528757
The evaluation of neutropenia in common variable immune deficiency patients.
Ghorbani M, Fekrvand S, Shahkarami S, Yazdani R, Sohani M, Shaghaghi M, Hassanpour G, Mohammadi J, Negahdari B, Abolhassani H, Aghamohammadi A. Ghorbani M, et al. Among authors: shaghaghi m. Expert Rev Clin Immunol. 2019 Nov;15(11):1225-1233. doi: 10.1080/1744666X.2020.1677154. Epub 2019 Oct 15. Expert Rev Clin Immunol. 2019. PMID: 31592698 Clinical Trial.
74 results